Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krish Patel

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|April 12, 2017
Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfectionJames B Maurice, Amee Patel, Alasdair J Scott, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 9, 2023
CAR-T Cell Therapy in India: Challenges and Opportunities for AdvancementTarun Kumar Suvvari, Vinay Suresh, Krish Patel, et al.
Iscience|February 2, 2024
Vinorelbine causes a neuropathic pain-like state in mice via STING and MNK1 signaling associated with type I interferon inductionÚrzula Franco-Enzástiga, Keerthana Natarajan, Eric T David, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 3, 2019
Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrolleesKrish Patel, Vinjamuri S Sudhir, Shaum Kabadi, et al.
Advances in Therapy|June 25, 2024
Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell LymphomaJames Wu, Armin Ghobadi, Richard Maziarz, et al.
Breast Cancer Research and Treatment|June 18, 2013
Prevalence and impact of correlative science in breast cancer phase II trialsTian Zhang, Andrew Schneider, Erika P Hamilton, et al.
Haematologica|November 7, 2024
Cumulative review of hypertension in patients with chronic lymphocytic leukemia treated with acalabrutinibAlessandra Ferrajoli, George Follows, Yotvat Marmor, et al.
EGEMS (Washington, DC)|February 4, 2017
Development and Refinement of a Learning Health Systems Training ProgramNicholas G Wysham, Lynn Howie, Krish Patel, et al.
Expert Review of Cardiovascular Therapy|January 30, 2026
Trends and forecasting of mortality associated with obstructive sleep apnea and hypertension among older adults in the United States (1999-2035)Muhammad Umar, Syeda Simrah Shah, Sabahat Hafeez, et al.
Leukemia & Lymphoma|March 23, 2025
Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaNitin Jain, Toby A Eyre, Katherine B Winfree, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|April 12, 2017
Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfectionJames B Maurice, Amee Patel, Alasdair J Scott, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 9, 2023
CAR-T Cell Therapy in India: Challenges and Opportunities for AdvancementTarun Kumar Suvvari, Vinay Suresh, Krish Patel, et al.
Iscience|February 2, 2024
Vinorelbine causes a neuropathic pain-like state in mice via STING and MNK1 signaling associated with type I interferon inductionÚrzula Franco-Enzástiga, Keerthana Natarajan, Eric T David, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 3, 2019
Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrolleesKrish Patel, Vinjamuri S Sudhir, Shaum Kabadi, et al.
Advances in Therapy|June 25, 2024
Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell LymphomaJames Wu, Armin Ghobadi, Richard Maziarz, et al.
Breast Cancer Research and Treatment|June 18, 2013
Prevalence and impact of correlative science in breast cancer phase II trialsTian Zhang, Andrew Schneider, Erika P Hamilton, et al.
Haematologica|November 7, 2024
Cumulative review of hypertension in patients with chronic lymphocytic leukemia treated with acalabrutinibAlessandra Ferrajoli, George Follows, Yotvat Marmor, et al.
EGEMS (Washington, DC)|February 4, 2017
Development and Refinement of a Learning Health Systems Training ProgramNicholas G Wysham, Lynn Howie, Krish Patel, et al.
Expert Review of Cardiovascular Therapy|January 30, 2026
Trends and forecasting of mortality associated with obstructive sleep apnea and hypertension among older adults in the United States (1999-2035)Muhammad Umar, Syeda Simrah Shah, Sabahat Hafeez, et al.
Leukemia & Lymphoma|March 23, 2025
Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaNitin Jain, Toby A Eyre, Katherine B Winfree, et al.
Pageof 7